Position in DGX
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$1,352,875
+$137,997 QoQ
Shares Held
6,383
+3.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.94%
of 13F equity value
Holder Rank
#444
of 1,090 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026YANKCOM Partnership holds $2,599,880 across 6 Diagnostics & Research names. DGX ranks #1 (52.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DGX |
Quest Diagnostics Inc
This page
|
6,383 | $1,352,875 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
1,342 | $672,824 | |
| 3 | DHR |
Danaher Corp /De/
|
1,768 | $336,768 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
365 | $192,150 | |
| 5 | LH |
Labcorp Holdings Inc.
|
92 | $25,760 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
|
86 | $19,503 |
All Filings in DGX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,352,875 | 6,383 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $1,214,878 | 6,199 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $1,083,866 | 6,246 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $1,186,550 | 6,226 | Shares | Other | 2025-10-20 | |
| 2025-06-30 | $1,249,685 | 6,957 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,174,754 | 6,943 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $1,065,523 | 7,063 | Shares | Sole | 2025-01-27 | |
| No filing history on record for this holder in this stock. | ||||||